Association between biomarkers and clinical outcomes of lenvatinib + pembrolizumab in advanced renal cell carcinoma (RCC): Results from Study 111/KEYNOTE-146 Meeting Abstract
| Authors: | Lee, C. H.; Rasco, D. W.; Rao, A.; Taylor, M. H.; Hsieh, J. J.; Pinto, A.; Vogelzang, N. J.; Cao, Z. A.; Suttner, L.; Loboda, A.; Vajdi, A.; Predoiu, R. A.; Nebozhyn, M.; Lunceford, J.; Perini, R. F.; Matsui, J.; Minoshima, Y.; Dutcus, C. E.; Dutta, L.; Motzer, R. J. |
| Abstract Title: | Association between biomarkers and clinical outcomes of lenvatinib + pembrolizumab in advanced renal cell carcinoma (RCC): Results from Study 111/KEYNOTE-146 |
| Meeting Title: | 2022 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2022 Feb 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-20 |
| Language: | English |
| ACCESSION: | WOS:000771008900379 |
| DOI: | 10.1200/JCO.2022.40.6_suppl.375 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 375 -- Meeting was conducted online as well as in person -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
